Óscar María Beloqui Ruiz-rekin lankidetzan egindako argitalpenak (10)

2002

  1. Efficacy and toxicity of intra-arterial cisplatin and etoposide for advanced hepatocellular carcinoma

    Oncology, Vol. 62, Núm. 4, pp. 293-298

2000

  1. Hyperhomocysteinemia in liver transplant recipients: Prevalence and multivariate analysis of predisposing factors

    Liver Transplantation, Vol. 6, Núm. 5, pp. 614-618

1998

  1. Erratum: Prognosis of hepatocellular carcinoma in relation to treatment: A multivariate analysis of 178 patients from a single European institution (Surgery (1998) 124 (575-583))

    Surgery

  2. Prognosis of hepatocellular carcinoma i relation to treatment: A multivariate analysis of 178 patients from a single european institution

    Surgery, Vol. 124, Núm. 3, pp. 575-583

1996

  1. Anticardiolipin antibodies in chronic hepatitis C: Implication of hepatitis C virus as the cause of the antiphospholipid syndrome

    Hepatology, Vol. 23, Núm. 2, pp. 199-204

1994

  1. Partial splenic embolization for the treatment of hypersplenism in cirrhosis

    Revue Francaise de Gastro-Enterologie

1993

  1. Partial splenic embolization for the treatment of hypersplenism in cirrhosis

    Hepatology, Vol. 18, Núm. 2, pp. 309-314

1992

  1. Hepatitis B and C viral infections in patients with hepatocellular carcinoma

    Hepatology, Vol. 16, Núm. 3, pp. 637-641

  2. Splenic embolization prior to myelosuppressive treatment in hepatocarcinoma and active chronic hepatitis

    European Journal of Radiology, Vol. 15, Núm. 3, pp. 211-214

1991

  1. Hepatic vein involvement in hepatocellular carcinoma: Its disappearance with intra-arterial chemotherapy

    Regional Cancer Treatment, Vol. 4, Núm. 2, pp. 60-63